All Industries

Top Biotech Companies

3,138 Biotech companies, sorted by total funding raised.

Pacific Biosciences

Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...

Menlo Park, United States501–1000Biotech, Genomics
Convertible·$900.0M·Feb 2021
Candid Therapeutics

Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...

San Diego, United States11–50Biotech, Therapeutics
Venture Unknown·$875.0M·Mar 2026
Apeel Sciences

Apeel Sciences develops plant-based edible coatings that extend the shelf life of fresh produce, ...

Goleta, United States201–500Agtech, Food Tech
Series F·$874.1M·Jul 2025
Brii BiosciencesIPO

Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China a...

San Francisco Bay Area, United States51–200Biotech, Healthcare
Venture Unknown·$865.0M·May 2025
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Life Sciences, Biosimulation
Private Equity·$850.0M·Jan 2017
Ocular TherapeutixIPO

Biopharmaceutical company developing sustained-release hydrogel therapies targeting retinal disea...

Bedford, United States201–500healthtech, Biotech
Private Equity·$836.7M·Sep 2025
Parabilis Medicines

Precision medicine company pursuing previously undruggable disease targets using novel therapeuti...

Cambridge, United States201–500Biotech, Life Sciences
Series F·$812.0M·Jan 2026
Spiber

Japanese biotech company developing fermented Brewed Protein materials for sustainable textiles a...

Tokyo, Japan201–500Biotech, Manufacturing
Venture Unknown·$807.6M·Dec 2024
Perfect Day

Sustainable dairy protein from precision fermentation

Berkeley, United States51–200Biotech
Series E·$787.7M·Jan 2024
Gossamer BioIPO

Biopharmaceutical company developing seralutinib for the treatment of pulmonary arterial hyperten...

San Diego, United States51–200Biotech, Healthcare
Private Equity·$762.0M·Jul 2023
TheranosClosed

Blood testing technology company claiming miniaturized diagnostics

Palo Alto, United States501–1000Biotech, Healthcare
Venture Unknown·$750.0M·Jun 2014
Enveda Biosciences

Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...

Boulder, United States201–500Artificial Intelligence, Biotech
Series D·$740.0M·Sep 2025
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate Round·$730.0M·Dec 2025
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Life Sciences
Venture Unknown·$722.0M·Jul 2025
Odyssey Therapeutics

Clinical-stage biopharmaceutical company developing small molecule and protein therapeutics for a...

Boston, United States51–200Biotech, Healthcare
Series D·$700.0M·Sep 2025
EQRxClosed

Developing new medicines with the goal of expanding global access for patients

Cambridge, United States51–200Healthcare, Biotech
Series B·$700.0M·Jan 2021
FogPharma

Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...

Cambridge, United States51–200Biotech, Drug Discovery
Series F·$694.0M·Jan 2025
Generate BiomedicinesIPO

AI-powered generative biology platform creating novel protein therapeutics across antibodies, pep...

Cambridge, United States201–500Artificial Intelligence, Biotech
Corporate Round·$693.0M·Dec 2024
Orca Bio

Clinical-stage biotech developing high-precision allogeneic cell therapies to replace diseased bl...

Menlo Park, United States51–200Biotech, Healthcare
Series F·$692.0M·Dec 2025
Insilico MedicineIPO

AI-driven drug discovery company using generative AI and deep learning to design novel drug candi...

Hong Kong, Hong Kong201–500Artificial Intelligence, Biotech
Series E·$669.8M·Mar 2026
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series B·$650.0M·Oct 2025
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series D·$648.3M·Jul 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private Equity·$647.0M·Feb 2026
insitro

High-quality perturbational data generation and AI to discover new targets and enable drug discov...

South San Francisco, United States201–500Artificial Intelligence, Healthcare
Series C·$643.0M·Mar 2021
Owkin

Owkin combines life-science and machine learning expertise to make drug development and clinical ...

San Francisco, United States201–500Artificial Intelligence, Biotech
Corporate Round·$625.2M·Jan 2023